Skip to main content
. 2013 May 30;139(2):441–451. doi: 10.1007/s10549-013-2573-3

Table 6.

Common laboratory test abnormalities

Laboratory parameter Patients, n (%)
Exemestane (n = 149) Anastrozole (n = 149)
Gradea Gradea
3 4 Any 3 4 Any
Hemoglobin 1 (0.7) 0 28 (18.8) 4 (2.7) 0 39 (26.2)
Lymphocytes (absolute) 1 (0.7) 1 (0.7) 31 (20.8) 3 (2.0) 0 29 (49.5)
Neutrophils (absolute)b 1 (0.7) 0 10 (6.8) 2 (1.3) 0 18 (12.1)
WBCs (absolute) 0 0 14 (9.4) 1 (0.7) 0 17 (11.4)
ALT 0 0 21 (14.1) 0 0 19 (12.8)
ALP 0 0 65 (43.6) 0 0 68 (45.6)
AST 0 0 25 (16.8) 2 (1.3) 0 28 (18.8)
Creatinine 0 0 32 (21.5) 1 (0.7) 0 30 (20.1)
GGT 12 (8.1) 2 (1.4) 89 (60.1) 9 (6.0) 2 (1.3) 73 (49.0)
Hypercalcemia 0 1 (0.7) 20 (13.4) 0 0 11 (7.4)
Hyperglycemiab 8 (5.4) 0 76 (51.4) 8 (5.4) 0 71 (47.7)
Hyperkalemia 1 (0.7) 0 9 (6.0) 1 (0.7) 0 10 (10.1)
Hypoalbuminemia 0 NAc 16 (10.7) 9 (6.0) NAc 9 (6.0)

ALP alkaline phosphatase, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma-glutamyl transferase, NA not applicable, WBC white blood cell

aBased on Common Terminology Criteria for Adverse Events version 3.0 [44]

bFor this laboratory test, n = 148 in the exemestane group

cGrade 4 hypoalbuminemia is not defined in CTCAE version 3.0